Skip to main content

Mineralys Therapeutics, Inc.

MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001933414

In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Mineralys Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
5 insiders, $4.68M in total
Insiders trading
5
Net value
−$4.68M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Mineralys Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Mineralys Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Slingsby Brian TaylorDirector7,805,718IndirectSep 24, 20263
Warren EricChief Commercial Officer38,400Sep 22, 20264
Karydas DaphneDirector6,200Sep 17, 20265
Ferguson James J. IIIChief Medical Officer102,400Aug 12, 20261
Rodman David MalcomChief Medical Officer51,384Aug 12, 202623
Congleton JonChief Executive Officer603,621Jul 15, 20269
RA Capital Healthcare Fund LPDirector5,825,521IndirectMar 31, 20262
Ra Capital Management, L.P.Director5,825,521IndirectMar 31, 20262
Kolchinsky PeterDirector5,825,521IndirectMar 31, 20262
Shah Rajeev M.Director5,825,521IndirectMar 31, 20262
RA Capital Nexus Fund III, L.P.Director5,825,521IndirectMar 31, 20262
Akkaraju SrinivasDirector, 10% Owner6,200Feb 20, 20261
Sblendorio GlennDirector6,200Feb 20, 20261
Levy Adam ScottCFO and Secretary48,538Feb 20, 20264
DiRocco DerekDirector6,200Feb 20, 20261
Gold Alexander MDirector6,200Feb 20, 20262
Catalys Pacific Fund, LP10% Owner7,903,838IndirectNov 21, 20251
Samsara BioCapital, L.P.10% Owner5,674,916IndirectMar 17, 20250
Samsara BioCapital GP, LLC10% Owner5,674,916IndirectMar 17, 20250
Litzka OlivierDirector–May 23, 20240
Takahashi TakeshiDirector–Jul 14, 20230
HBM Healthcare Investments (Cayman) Ltd.10% Owner3,218,106Feb 16, 20230
Asam AlexanderDirector–Feb 13, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 15, 2025 (view filing)Jul 114 daysLevy Adam ScottCFO and SecretarySSale−10.8K$14.45−$155.5K−4.9%206.6K after10b5-1
Jul 15, 2025 (view filing)Jul 141 dayRodman David MalcomChief Medical OfficerSSale−11.4K$14.59−$165.8K−10.4%97.9K after10b5-1
Jun 16, 2025 (view filing)Jun 133 daysRodman David MalcomChief Medical OfficerSSale−11.4K$14.60−$165.9K−10.1%101.7K after10b5-1
May 15, 2025 (view filing)May 141 dayRodman David MalcomChief Medical OfficerSSale−11.4K$15.29−$173.8K−9.6%106.7K after10b5-1
Apr 25, 2025 (view filing)7:01 PM ETMar 1343 daysLateSlingsby Brian Taylor and 1 otherDirector, 10% OwnerPPurchase+259.3K$13.50+$3.50M+3.0%8.90M after
Apr 15, 2025 (view filing)Apr 141 dayRodman David MalcomChief Medical OfficerSSale−11.4K$14.53−$165.2K−9.2%111.7K after2 lots10b5-1
Apr 15, 2025 (view filing)Apr 114 daysLevy Adam ScottCFO and SecretarySSale−10.8K$12.06−$129.7K−4.8%215.3K after10b5-1
Apr 15, 2025 (view filing)Apr 114 daysCongleton JonChief Executive OfficerSSale−15.3K$12.19−$186.7K−1.7%862.3K after10b5-1
Apr 3, 2025 (view filing)Apr 12 daysRodman David MalcomChief Medical OfficerSSale−55.8K$15.76−$879.1K−32.3%116.7K after3 lots10b5-1
Mar 17, 2025 (view filing)9:05 PM ETMar 134 daysSamsara BioCapital, L.P. and 1 other10% OwnerPPurchase+600.0K$13.50+$8.10M+11.8%5.67M afterDuplicate filing
Mar 17, 2025 (view filing)7:56 PM ETMar 134 daysRA Capital Healthcare Fund LP and 4 othersDirectorPPurchase+1.30M$13.50+$17.5M+43.4%4.28M after
Mar 17, 2025 (view filing)Mar 134 daysAkkaraju SrinivasDirectorPPurchase+600.0K$13.50+$8.10M+11.8%5.67M after
Jan 15, 2025 (view filing)Jan 132 daysLevy Adam ScottCFO and SecretarySSale−10.8K$9.10−$97.8K−4.5%226.1K after2 lots10b5-1
Jan 15, 2025 (view filing)Jan 132 daysCongleton JonChief Executive OfficerSSale−18.3K$9.06−$166.1K−2.0%877.6K after10b5-1
Nov 12, 2024 (view filing)Nov 111 dayRodman David MalcomChief Medical OfficerSSale−5.03K$15.00−$75.4K−3.4%141.0K after10b5-1
Nov 8, 2024 (view filing)Nov 62 daysRodman David MalcomChief Medical OfficerSSale−25.5K$15.03−$383.0K−15.8%136.0K after10b5-1
Oct 15, 2024 (view filing)Oct 114 daysLevy Adam ScottCFO and SecretarySSale−10.8K$13.57−$146.0K−4.3%236.9K after10b5-1
Oct 15, 2024 (view filing)Oct 114 daysCongleton JonChief Executive OfficerSSale−15.3K$13.52−$206.5K−1.7%895.9K after10b5-1
Jul 26, 2024 (view filing)9:45 PM ETJul 242 daysSlingsby Brian Taylor and 1 otherDirector, 10% OwnerSSale−550.0K$13.05−$7.18M−6.0%8.64M after
Jul 18, 2024 (view filing)Jul 162 daysRodman David MalcomChief Medical OfficerSSale−525$15.00−$7.88K−0.5%102.9K after10b5-1
Jul 12, 2024 (view filing)Jul 111 dayLevy Adam ScottCFO and SecretarySSale−10.8K$13.14−$141.3K−4.2%247.6K after10b5-1
Jul 12, 2024 (view filing)Jul 111 dayCongleton JonChief Executive OfficerSSale−15.7K$13.34−$210.1K−1.7%911.2K after10b5-1
Jun 20, 2024 (view filing)Jun 17-203 daysCongleton JonChief Executive OfficerSSale−49.3K$12.00−$592.0K−5.1%927.0K after3 lots10b5-1
Jun 14, 2024 (view filing)Jun 12-142 daysCongleton JonChief Executive OfficerSSale−72.8K$12.70−$924.4K−6.9%976.3K after3 lots10b5-1
Jun 13, 2024 (view filing)Jun 112 daysLevy Adam ScottCFO and SecretarySSale−96.8K$12.94−$1.25M−27.5%255.5K after10b5-1
May 10, 2024 (view filing)May 91 dayRodman David MalcomChief Medical OfficerSSale−100$15.00−$1.50K−0.1%67.0K after10b5-1
Feb 14, 2024 (view filing)9:06 PM ETFeb 122 daysSamsara BioCapital, L.P. and 1 other10% OwnerPPurchase+555.6K$13.50+$7.50M+12.3%5.07M after
Nov 27, 2023 (view filing)Nov 225 daysCongleton JonChief Executive OfficerPPurchase+4.25K$5.97+$25.4K+0.4%1.05M after
Sep 8, 2023 (view filing)Sep 62 daysCongleton JonChief Executive OfficerPPurchase+2.25K$12.08+$27.2K+0.2%1.04M after
Aug 21, 2023 (view filing)Aug 174 daysCongleton JonChief Executive OfficerPPurchase+2.25K$12.10+$27.2K+0.2%1.04M after
Aug 11, 2023 (view filing)Aug 10-111 dayRodman David MalcomChief Medical OfficerSSale−231.7K$12.92−$2.99M−100.0%0 after3 lots
Aug 11, 2023 (view filing)Aug 11Same dayCongleton JonChief Executive OfficerPPurchase+2.00K$12.89+$25.8K+0.2%1.04M after
Feb 16, 2023 (view filing)5:04 PM ETFeb 142 daysRA Capital Healthcare Fund LP and 4 othersDirectorPPurchase+1.25M$16.00+$20.0M+2,040.9%1.31M after2 lots
Feb 16, 2023 (view filing)4:54 PM ETFeb 142 daysAkkaraju Srinivas and 1 otherDirector, 10% OwnerPPurchase+937.5K$16.00+$15.0M+26.2%4.52M after
Feb 16, 2023 (view filing)4:54 PM ETFeb 142 daysSlingsby Brian Taylor and 1 otherDirector, 10% OwnerPPurchase+250.0K$16.00+$4.00M+2.8%9.19M after
Feb 16, 2023 (view filing)Feb 142 daysLevy Adam ScottCFO, Chief Bus. Off. and Secy.PPurchase+6.25K$16.00+$100.0K+1.8%350.8K after
Feb 16, 2023 (view filing)Feb 142 daysHBM Healthcare Investments (Cayman) Ltd.10% OwnerPPurchase+312.5K$16.00+$5.00M+10.8%3.22M after